Aegerion Pharmaceuticals, Inc. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aegerion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aegerion Pharmaceuticals, Inc. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Option Exercise | M | 17.64 | 7,500 | 132,300 | 192,150 | |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Sell | S | 64.69 | 486 | 31,439 | 5,850 | 6.3 K to 5.9 K (-7.67 %) |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Sell | S | 63.72 | 900 | 57,348 | 6,336 | 7.2 K to 6.3 K (-12.44 %) |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Sell | S | 62.94 | 2,814 | 177,113 | 7,236 | 10.1 K to 7.2 K (-28.00 %) |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Sell | S | 61.71 | 3,300 | 203,643 | 10,050 | 13.4 K to 10.1 K (-24.72 %) |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Buy | M | 17.64 | 7,500 | 132,300 | 13,350 | 5.9 K to 13.4 K (+128.21 %) |
| Feb 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | M | 13.01 | 2,000 | 26,020 | 115,000 | |
| Feb 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Sell | S | 64.52 | 500 | 32,260 | 0 | 500 to 0 (-100.00 %) |
| Feb 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Sell | S | 63.14 | 1,500 | 94,710 | 500 | 2 K to 500 (-75.00 %) |
| Feb 18 2014 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Buy | M | 13.01 | 2,000 | 26,020 | 2,000 | 0 to 2 K |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fraser Craig | Pres., US/Int. Comm ... | Option Exercise | M | 13.01 | 2,250 | 29,273 | 71,000 | |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fraser Craig | Pres., US/Int. Comm ... | Sell | S | 67.00 | 2,250 | 150,750 | 0 | 2.3 K to 0 (-100.00 %) |
| Feb 12 2014 | AEGR | Aegerion Pharmaceu ... | Fraser Craig | Pres., US/Int. Comm ... | Buy | M | 13.01 | 2,250 | 29,273 | 2,250 | 0 to 2.3 K |